S6.B — SPECIFIED STIMULANTS Internationaal Verdrag tegen doping in de sport
SPECIFIED STIMULANTS
Including, but not limited to:
2-phenylpropan-1-amine (ß-methylphenylethyl-amine, BMPEA)
3-Methylhexan-2-amine (1,2-dimethylpentylamine)
4-Fluoromethylphenidate
4-Methylhexan-2-amine (1,3-dimethylamylamine, 1,3 DMAA, methylhexaneamine)
4-Methylpentan-2-amine (1,3-dimethylbutylamine)
5-Methylhexan-2-amine (1,4-dimethylamylamine, 1,4-dimethylpentylamine, 1,4-DMAA)
Benzfetamine
Cathine
2) Cathine (d-norpseudoephedrine) and its l-isomer: Prohibited when its concentration in urine is greater than 5 micrograms per millilitre.
Cathinone and its analogues, e.g. mephedrone, methedrone, and α-pyrrolidinovalerophenone
Dimetamfetamine (dimethylamphetamine)
Ephedrine
3) Ephedrine and methylephedrine: Prohibited when the concentration of either in urine is greater than 10 micrograms per millilitre.
Epinephrine
4) Epinephrine (adrenaline): Not prohibited in local administration, e.g. nasal, ophthalmologic, or co-administration with local anaesthetic agents.
(adrenaline)
Etamivan
Ethylphenidate
Etilamfetamine
Etilefrine
Famprofazone
Fenbutrazate
Fencamfamin
Heptaminol
Hydroxyamfetamine (parahydroxyamphetamine)
Isometheptene
Levmetamfetamine
Meclofenoxate
Methylenedioxymethamphetamine
Methylephedrine
5) Ephedrine and methylephedrine: Prohibited when the concentration of either in urine is greater than 10 micrograms per millilitre.
Methylnaphthidate [(±)-methyl-2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate]
Methylphenidate
Midodrine
Nikethamide
Norfenefrine
Octodrine (1,5-dimethylhexylamine)
Octopamine
Oxilofrine (methylsynephrine)
Pemoline
Pentetrazol
Phenethylamine and its derivatives
Phenmetrazine
Phenpromethamine
Propylhexedrine
Pseudoephedrine
6) Pseudoephedrine: Prohibited when its concentration in urine is greater than 150 micrograms per millilitre.
Selegiline
Sibutramine
Solriamfetol
Strychnine
Tenamfetamine (methylenedioxyamphetamine)
Tesofensine
Tuaminoheptane
and other substances with a similar chemical structure or similar biological effect(s).
EXCEPTIONS
• Clonidine, guanfacine;
• Imidazoline derivatives for dermatological, nasal, ophthalmic or otic use (e.g. brimonidine, clonazoline, fenoxazoline, indanazoline, naphazoline, oxymetazoline, tetryzoline, tramazoline, xylometazoline) and those stimulants included in the 2026 Monitoring Program
7) Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, and synephrine: These substances are included in the 2026 Monitoring Program and are not considered Prohibited Substances.
.
- Regeling
- Internationaal Verdrag tegen doping in de sport
- Soort
- Verdrag
- Geldend vanaf
- 01-01-2026
- BWB-id
- BWBV0001829
- Versie
- 2026-01-01_0